节点文献

卡托普利对高血压与血管结构及功能的分离效应(英文)

Disparate effects of captopril on hypertension and blood vessel

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 陈达光晋学庆王华军陈松苍

【Author】 CHEN Da-Guang, JIN Xue-Qing, WANG Hua-Jun, CHEN Song-Cang(Hypertension Division, First Affiliated Hospital, Fujian Medical College, Fuzhou 350005, China)

【机构】 福建医学院附属第一医院高血压研究室福建医学院附属第一医院高血压研究室 福州 350005 中国福州 350005 中国福州 350005 中国

【摘要】 目的:研究卡托普利(Cap)对血管的结构与功能的作用是否与其降压作用分离。方法:SHR从胎仔期起分别接受Cap 20与100mg·kg-1·d-1,A组和B组)至生后16周停药,40周实验。血压用尾动脉法测定。肠系膜动脉第三级分支的壁/腔比测定用形态计量法,阻力血管性质测定用后肢灌注压对递增量phenylephrine,灌注液内加L-NAME或L-arginine。结果:两种剂量的Cap都能完全 防止血管壁肥厚(肠系膜动脉第三级分支的壁/腔比Cap A:0.38±0.08,Cap B:0.29±0.05 vsWKY:0.34±0.11,P>0.05)结果与WKY者类似。Cap组后肢灌注压曲线的参数与WKY组几乎完全相同,与未治疗SHR有明显差别(EC50,Cap B:4.05±2.58 vs SHR:1.15±0.96 mL·L-1,P<0.01,vs WKY:5.13±1.97mL·L-1,P>0.05)。在灌注液内加入L-NAME或L-arginine可加强或减弱Cap治疗组的血管收缩反应。结论:Cap从胎仔期治疗可以使SHR的阻力血管结构与收缩反应正常化,而血压仍维持在不同程度的较高水平。

【Abstract】 AIM: To study whether the effect of captopril (Cap) on vascular structure and function may be separated from its effect on blood pressure. METHODS: Captopril treatment ( group Cap A and B, 20 and 100 mg·kg-1·d-1) was given to SHR rats during pregnancy, weaning, and up to 16 wk of age. Study performed at 40 wk. Blood pressure ( BP) was measured by tail-cuff sphygmo-manometer, and wall/lumen ratio of mesenteric artery 3rd grade branch was assessed by morphome-tric assay. Resistance vessel properties were determined by hindquarter perfusion pressure responses to incremental doses of phenylephrine, in the presence of Nw nitro-L-arginine methyl ester ( L-NAME) or the L-arginine, the precursor of nitric oxide synthesis. RESULTS: Both doses of Cap prevented hypertrophy of blood vessels to an extent comparable to that of the untreated WKY rats (wall/lumen ratio of mesenteric artery, Cap A: 0.38 ± 0.08, CapB: 0.29 ±0.05 vs WKY: 0.34±0.11, P>0.05, respectively) . The parameters derived from hindquarter perfusion pressure curves in Cap treated group were almost identical to that of WKY, significantly different from that of untreated SHR (EC50, Cap B 4.05 μ2.58 vs SHR 1.15±0.96mL·L-1, P<0.01; vs WKY 5.13 ± 1.97 mL · L-1, P > 0.05). Addition of L-NAME or L-arginine in the perfusate augmented or attenuated the vasoconstriction responses in the Cap treated group. CONCLUSION; Cap initiated from in-trauterine period normalized the vascular structure and vasoconstrictive responses in SHR when BP still sustained at a higher level vs WKY.

【基金】 supported by the National Natural Science Fundation of China,№ 3880409;Presented at 15th Scientific Meeting of International Society of Hypertension (Melbournet,1994 Mar 20-24).
  • 【文献出处】 Acta Pharmacologica Sinica ,中国药理学报(英文版) , 编辑部邮箱 ,1996年02期
  • 【分类号】R96
  • 【被引频次】2
  • 【下载频次】12
节点文献中: 

本文链接的文献网络图示:

本文的引文网络